tiprankstipranks
Cero Therapeutics Holdings, Inc. (CERO)
OTHER OTC:CERO
US Market
CERO
CERo Therapeutics Holdings
RESEARCH TOOLSreports
Want to see CERO full AI Analyst Report?

CERo Therapeutics Holdings (CERO) Income Statement

500 Followers

CERo Therapeutics Holdings Income Statement

Last quarter (Q4 2025), CERo Therapeutics Holdings's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, CERo Therapeutics Holdings's net income was $-4.54M. See CERo Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.09M$ -1.16M$ -1.12M$ 0.00$ 0.00
Operating Expenses
$ 17.38M$ 15.30M$ 2.93M$ 2.91M$ 431.50K
Depreciation and Amortization
$ 1.09M$ 1.16M$ 2.93K$ 2.91M$ 735.47K
EBITDA
$ -17.38M$ -6.57M$ -2.44M$ -68.58K$ 403.06K
Operating Income
$ -18.46M$ -15.30M$ -2.93M$ -2.91M$ -332.03K
Other Income/Expenses
$ -1.46M$ 7.57M$ 491.57K$ 2.84M$ -385.00
Pretax Income
$ -19.92M$ -7.73M$ -2.44M$ -68.58K$ -332.42K
Net Income
$ -19.92M$ -7.73M$ -2.54K$ -667.74K$ -315.55K
Per Share Metrics
Basic EPS
$ -22.58$ -6.87$ -2.50K$ -19.73$ -2.75
Diluted EPS
$ -22.58$ -6.87$ -2.50K$ -19.73$ -2.75
Weighted Average Shares Outstanding
 4.23M 120.79K 7.35K 7.35K 7.35K
Weighted Average Shares Outstanding (Diluted)
 4.23M 120.79K 7.35K 7.35K 7.35K
Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History